TY  - GEN
AU  - Subbiah,Vivek
AU  - Hess,Kenneth R
AU  - Khawaja,Muhammad Rizwan
AU  - Wagner,Michael J
AU  - Tang,Chad
AU  - Naing,Aung
AU  - Fu,Siqing
AU  - Janku,Filip
AU  - Piha-Paul,Sarina
AU  - Tsimberidou,Apostolia M
AU  - Herzog,Cynthia E
AU  - Ludwig,Joseph A
AU  - Patel,Shreyaskumar
AU  - Ravi,Vinod
AU  - Benjamin,Robert S
AU  - Meric-Bernstam,Funda
AU  - Hong,David S
TI  - Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies
SN  - 2045-2322
PY  - 2018///0423
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers
KW  - Clinical Trials, Phase I as Topic
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - methods
KW  - Neoplasm Metastasis
KW  - Retreatment
KW  - Sarcoma
KW  - diagnosis
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/srep35448
ER  -